| Quarter | Score |
|---|---|
| 2018-Q1 | 48.0 |
| 2018-Q2 | 54.7 |
| 2018-Q3 | 52.1 |
| 2019-Q2 | 48.6 |
| 2022-Q3 | 41.1 |
| 2022-Q4 | 49.2 |
| 2023-Q1 | 49.0 |
| 2023-Q2 | 66.8 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 65.9 |
| 2024-Q1 | 63.4 |
| 2024-Q2 | 73.6 |
| 2024-Q3 | 72.2 |
| 2024-Q4 | 74.1 |
| 2025-Q1 | 77.4 |
| 2025-Q2 | 79.9 |
| 2025-Q3 | 87.4 |
| 2025-Q4 | 43.1 |
| 2026-Q1 | 45.5 |
| 2026-Q2 | 48.2 |
Stable institutional holding; maintain existing positions
Trading 83.3% below funds' estimated purchase price
1 of 16 tracked funds hold CVNA. Avg conviction: 6.1%. Net adding. First tracked at $422.02 (current -83.3% vs tracked).
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Sachem Head Capital | 6.1% | Add |